LHR
RVMD icon

Lunate Holding RSC’s Revolution Medicines RVMD Stock Holding History

Lunate Holding RSC’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$96.1M Buy
+2,196,200
New +$111M 45.54% 1

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Lunate Holding RSC's RVMD Position: Q4 2024 in Review

Lunate Holding RSC opened a new position in Revolution Medicines (RVMD) in Q4 2024: 2,196,200 shares worth $96.1M. The stake represents 45.54% of the portfolio and ranks #1 among its holdings.

281 funds tracked by Wall St. Rank hold RVMD as of Q4 2024.

  • Lunate Holding RSC held 2,196,200 shares of Revolution Medicines worth $96.1M as of Q4 2024.
  • Revolution Medicines was a new Lunate Holding RSC position in Q4 2024.
  • Revolution Medicines made up 45.54% of Lunate Holding RSC's portfolio in Q4 2024, its #1 holding.
  • 281 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2024.

Based on Lunate Holding RSC's 13F filing for Q4 2024, filed 14 Feb 2025.